Patent · US Expired

2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action

US7427610B2 · kind B2 · utility

6Cited by
3References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 19, 2004
Grant dateSep 23, 2008
Priority date
Expiry dateFeb 19, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J41/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds of formula Iand use thereof in a method of treating a tumor disease that can be influenced positively by the inhibition of tubulin polymerization.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.